Nemours 2025 Gala Supports Pediatric Cancer Research
Epi One CEO Michael Marquardt recently had the honor of attending the annual gala of the Nemours Children’s Health System with his wife Claire, who serves ...
Read More Epi One Debuts Early Detection Assay Data at AACR 2025 Annual Meeting
Last week marked a milestone for Epi One: we presented for the first time at the American Association for Cancer Research (AACR) Annual Meeting in Chicago — ...
Read More American Cancer Society Medal of Honor Ceremony
Epi One CEO Michael Marquardt had the privilege of attending the American Cancer Society Medal of Honor ceremony in Washington, D.C. recently. The Award is ACS' ...
Read More Epi One March Update
Epi One CEO Michael Marquardt provides an update on the latest news on developments in our current laboratory, our search for additional lab space in Delaware, ...
Read More Epi One to Present Poster Session at AACR Conference
We are delighted to confirm that we will be presenting a poster session at this year's American Association for Cancer Research conference, which runs from 25 ...
Read More Epi One Raises $2.1 Million in Successful Equity Crowdfunding Campaign
Epi One, a trailblazer in cancer diagnostics, is thrilled to announce the successful conclusion of its equity crowdfunding campaign on StartEngine, which raised an impressive $2.1 ...
Read More Transforming Early Cancer Detection: Latest Webinar Highlights
At Epi One, we're on a mission to revolutionize how cancer is detected and diagnosed. During our recent webinar, our CEO, Michael Marquardt, and fellow healthcare ...
Read More Join Us for Epi One’s Final Investment Webinar – A Conversation with CEO Michael Marquardt and Chief Scientist & Founder Dr. Fang
As our StartEngine campaign enters its final weeks, we're excited to invite you to a special webinar event on November 26th at 4:30 PM Eastern Time. ...
Read More Epi One: Top Reasons to Invest Today
7 Reasons to Invest in Epi One: Transforming Cancer Detection Imagine a world where a simple test could detect cancer at its earliest stages, long before ...
Read More Interested in Learning More?
Sign up for our Insider Waiting List
Join our journey toward a future where cancer diagnosis is faster, more accurate, and more accessible than ever before.